Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors

NCT05364450 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT05364450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05364450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Completed
Start date
August 17, 2021
Completion date
July 9, 2024
Enrollment
390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, breast cancer, breast carcinoma, breast neoplasm, cancer of breast, fear, human mammary carcinoma, malignant neoplasm of breast, malignant tumor of breast, mammary cancer, mammary carcinoma, human, mammary neoplasms, human